What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology, Platform, Specimen, Application, End User, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

Publish Date: Mar, 2019
Report ID: 376055
Category: Medical Devices
Pages: 0

$4700

Global immunoassay market is expected to reach USD 20.71 Billion in 2017 to USD 40.29 Billion by 2025 at a CAGR of 8.40% from 2018 to 2025. Increasing cases of infections and life-threatening diseases, rising population and requirement of innovative assays for autoimmune diseases, oncology and cardiology for the diagnosis are expected to fuel the growth of the market.

Market Overview:

Immunoassay is a biochemical which is used for the detection of various substances or specific proteins in the samples. The immunoassay instruments also identified as analyzers are used in hospitals and clinical laboratories. These instruments help in detecting the concentration and presence of analytes in the blood, plasma and urine samples. This technique uses antibody binding phenomenon, and the concentration of proteins is measured using the specific antigen-antibody binding properties. The applications of using immunoassay instruments are the minimal human resistance and screening of multiple samples.

Report Description:

The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The immunoassay market is analyzed by value (USD Billion).
The study delivers a comprehensive analysis of the global immunoassay market by product and service, technology, platform, specimen, application, end user and regions.
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
Porter’s Five Forces model is used to recognize the competitive scenario in the global immunoassay market. This report incorporates the industry analysis which is focused on providing an extensive view of the immunoassay market.
The study also includes attractiveness analysis of product and service, technology, platform, specimen, application, end user, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
The report provides company profile of the key players operating in the immunoassay market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

Increasing cases of chronic and infectious diseases
Increasing adoption of immunoassays in oncology
Technological advancements and the introduction of innovative in immunoassay instruments
Growth in the biotechnology and biopharmaceutical industries
Vital Role of immunoassays in drug and alcohol testing

Restraints:

Excise duty on the sale of medical devices
Unfavorable reimbursement scenario
Stringent regulatory requirements for the approval of immunoassay instruments

Opportunities:

The increasing importance of companion diagnostics in the immunoassays market
Development of condition-specific biomarkers and tests

Challenges:

Complexities in conducting diagnostic tests

Global Immunoassay Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The immunoassay market is segmented by product and service, technology, platform, specimen, application, and end user.

The product and service segment is classified into reagents & kits, analyzers and software. The reagents & kits segment is dominating the market and held the largest market share of 48.20% in 2017. Rising global demand for non-invasive diagnostics techniques and growing need of reagents are driving the growth of the segment.
Technology segment is divided into ELISA, Rapid Tests, western blotting, ELISPOT, immuno-PCR, and other technologies. ELISPOT was dominating the segment and was valued at around USD 6.83 billion in 2017. Owing to its high sensitivity, cost benefits and long term presence in the market is contributing to the growth of the segment.
Platform segment is classified into chemiluminescence immunoassays, fluorescence immunoassays, colorimetric immunoassays, radioimmunoassays, and other platforms. The chemiluminescence immunoassays segment is expected to grow at a significant CAGR of 10.73% in the forecast period. This growth can be attributed to attribute automation and high-throughput techniques offered by the procedure as compared to others.
Application segment is divided into infectious diseases, oncology, endocrinology, cardiology, bone & mineral disorders, hematology & blood screening, autoimmune disorders, neonatal screening, toxicology, and other applications. The infectious disease segment accounted for the largest market share of 34.31% in 2017. Increasing population prone to infections is rising demand of these assays which in turn is driving the growth of the segment.
The end user segment includes hospitals, clinical laboratories, pharmaceutical, and biotechnology industries, blood banks, research & academic laboratories and others end users. Rising demand for high-sensitivity test and convenient access, increasing demand for the rapid test result.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region dominated the global immunoassay market and generated the largest revenue of USD 9.52 Billion in 2017 whereas the Asia Pacific is expected to register the highest growth in the forecast period.

North America region is expected to dominate the market due to the increasing application of immunoassay techniques in cancer research is a major driver of the market. Increasing adoption of compact immunoassay instruments in clinical diagnostics and increasing quality of infrastructure for laboratory and clinical research are also fuelling the growth of the market in the region.
The Asia Pacific is expected to register the highest growth in the forecast period. Increasing development of new biologics, vaccines, and drugs and expanding medical treatment for infectious and chronic diseases are favoring the growth of the market in the region. Growing investment opportunities in emerging markets and the increasing number of diagnostics laboratories in the region attracting international and domestic players in the market.

Global Immunoassay Market Competitive Analysis:

Major players operating in the immunoassay market are Abbott Laboratories, Siemens, Roche, Sysmex Corporation, Danaher Corporation, bioMérieux, DiaSorin, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN, Becton, Dickinson and Company, Agilent Technologies, Merck, Quidel Corporation, PerkinElmer, Mindray, Bio-Techne Corporation and others. Market participants are engaged in various strategies to increase their footprints in the market. For instance, in 2017, Qiagen received approval for QFT-Plus from FDA, which is used for the detection of latent tuberculosis infection.

This study forecasts revenue growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global immunoassay market by below-mentioned segments:

Global Immunoassay Market, By Product & Service:

Reagents & Kits
- Elisa Reagents & Kits
- Rapid Test Reagents & Kits
- Elispot Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
Analyzers
Software & Services

Global Immunoassay Market, By Platform:

Chemiluminescence Immunoassays
Fluorescence Immunoassays
Colorimetric Immunoassays
Radioimmunoassays
Other Platforms

Global Immunoassay Market, By Technology:

Enzyme-Linked Immunosorbent Assays
Rapid Tests
Enzyme-Linked Immunospot
Immuno-PCR
Western Blotting
Other Technologies

Global Immunoassay Market, By Specimen Type:

Blood
Saliva
Urine
Other Specimens

Global Immunoassay Market, By Application:

Infectious Diseases
Oncology
Endocrinology
Bone & Mineral Disorders
Autoimmune Disorders
Cardiology
Neonatal Screening
Hematology & Blood Screening
Toxicology
Other Applications

Global Immunoassay Market, By End User:

Hospitals
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Blood Banks
Research & Academic Laboratories
Other End Users

Global Immunoassay Market, By Regions:

North America

The U.S.
Canada
Mexico

Europe

Germany
France
Sweden
Netherlands
U.K.
Italy
Spain
Turkey
Switzerland
Belgium
Rest of Europe

Asia-Pacific

Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia-Pacific

South America

Brazil
Argentina
Colombia
Rest of South America

The Middle East and Africa

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of Middle East and Africa

*All our reports are customizable as per customer requirements

Request Sample Request for Customization

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market attractiveness analysis by product and service
4.3.2. Market attractiveness analysis by technology
4.3.3. Market attractiveness analysis by platform
4.3.4. Market attractiveness analysis by specimen
4.3.5. Market attractiveness analysis by application
4.3.6. Market attractiveness analysis by end user
4.3.7. Market attractiveness analysis by region
4.4. Industry Trends

5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing cases of chronic and infectious diseases
5.2.2. Increasing adoption of immunoassays in oncology
5.2.3. Technological advancements and introduction of innovative in immunoassay instruments
5.2.4. Growth in the biotechnology and biopharmaceutical industries
5.3. Restraints
5.3.1. Excise duty on the sale of medical devices
5.3.2. Unfavourable reimbursement policies
5.4. Opportunities
5.4.1. Increasing importance of companion diagnostics in the immunoassays market
5.4.2. Development of condition-specific biomarkers and tests
5.5. Challenges
5.5.1. Complexities in conducting diagnostic tests

6. Global Immunoassay Market Analysis and Forecast, By Product & Service
6.1. Segment Overview
6.2. Reagents & Kits
6.2.1. Elisa Reagents & Kits
6.2.2. Rapid Test Reagents & Kits
6.2.3. Elispot Reagents & Kits
6.2.4. Western Blot Reagents & Kits
6.2.5. Other Reagents & Kits
6.3. Analyzers
6.4. Software & Services

7. Global Immunoassay Market Analysis and Forecast, By Platform
7.1. Segment Overview
7.2. Chemiluminescence Immunoassays
7.3. Fluorescence Immunoassays
7.4. Colorimetric Immunoassays
7.5. Radioimmunoassays
7.6. Other Platforms

8. Global Immunoassay Market Analysis and Forecast, By Technology
8.1. Segment Overview
8.2. Enzyme-Linked Immunosorbent Assays
8.3. Rapid Tests
8.4. Enzyme-Linked Immunospot
8.5. Immuno-PCR
8.6. Western Blotting
8.7. Other Technologies

9. Global Immunoassay Market Analysis and Forecast, By Specimen Product and service
9.1. Segment Overview
9.2. Blood
9.3. Saliva
9.4. Urine
9.5. Other Specimens

10. Global Immunoassay Market Analysis and Forecast, By Application
10.1. Segment Overview
10.2. Infectious Diseases
10.3. Oncology
10.4. Endocrinology
10.5. Bone & Mineral Disorders
10.6. Autoimmune Disorders
10.7. Cardiology
10.8. Neonatal Screening
10.9. Hematology & Blood Screening
10.10. Toxicology
10.11. Other Applications

11. Global Immunoassay Market Analysis and Forecast, By End User
11.1. Segment Overview
11.2. Hospitals
11.3. Clinical Laboratories
11.4. Pharmaceutical and Biotechnology Companies
11.5. Blood Banks
11.6. Research & Academic Laboratories
11.7. Other End Users

12. Global Immunoassay Market Analysis and Forecast, By Regional Analysis
12.1. Segment Overview
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.2.3. Mexico
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. Sweden
12.3.4. Netherlands
12.3.5. U.K.
12.3.6. Italy
12.3.7. Spain
12.3.8. Turkey
12.3.9. Switzerland
12.3.10. Belgium
12.3.11. Rest of Europe
12.4. Asia-Pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. South Korea
12.4.5. Australia
12.4.6. Singapore
12.4.7. Malaysia
12.4.8. Thailand
12.4.9. Indonesia
12.4.10. Philippines
12.4.11. Rest of Asia-Pacific
12.5. South America
12.5.1. Brazil
12.5.2. Argentina
12.5.3. Colombia
12.5.4. Rest of South America
12.6. Middle East and Africa
12.6.1. Saudi Arabia
12.6.2. UAE
12.6.3. Egypt
12.6.4. Nigeria
12.6.5. South Africa
12.6.6. Rest of Middle East and Africa

13. Global Immunoassay Market-Competitive Landscape
13.1. Overview
13.2. Market Share of Key Players in the Immunoassay Market
13.2.1. Global Company Market Share
13.2.2. North America Company Market Share
13.2.3. Europe Company Market Share
13.2.4. APAC Company Market Share
13.3. Competitive Situations and Trends
13.3.1. Product Launches and Developments
13.3.2. Partnerships, Collaborations, and Agreements
13.3.3. Mergers & Acquisitions
13.3.4. Expansions

14. Company Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Company Market Share Analysis
14.1.4. Company Product Portfolio
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Siemens
14.2.1. Business Overview
14.2.2. Company Snapshot
14.2.3. Company Market Share Analysis
14.2.4. Company Product Portfolio
14.2.5. Recent Developments
14.2.6. SWOT Analysis
14.3. Roche
14.3.1. Business Overview
14.3.2. Company Snapshot
14.3.3. Company Market Share Analysis
14.3.4. Company Product Portfolio
14.3.5. Recent Developments
14.3.6. SWOT Analysis
14.4. Sysmex Corporation
14.4.1. Business Overview
14.4.2. Company Snapshot
14.4.3. Company Market Share Analysis
14.4.4. Company Product Portfolio
14.4.5. Recent Developments
14.4.6. SWOT Analysis
14.5. Danaher Corporation
14.5.1. Business Overview
14.5.2. Company Snapshot
14.5.3. Company Market Share Analysis
14.5.4. Company Product Portfolio
14.5.5. Recent Developments
14.5.6. SWOT Analysis
14.6. bioMérieux
14.6.1. Business Overview
14.6.2. Company Snapshot
14.6.3. Company Market Share Analysis
14.6.4. Company Product Portfolio
14.6.5. Recent Developments
14.6.6. SWOT Analysis
14.7. DiaSorin
14.7.1. Business Overview
14.7.2. Company Snapshot
14.7.3. Company Market Share Analysis
14.7.4. Company Product Portfolio
14.7.5. Recent Developments
14.7.6. SWOT Analysis
14.8. Ortho Clinical Diagnostics
14.8.1. Business Overview
14.8.2. Company Snapshot
14.8.3. Company Market Share Analysis
14.8.4. Company Product Portfolio
14.8.5. Recent Developments
14.8.6. SWOT Analysis
14.9. Bio-Rad Laboratories
14.9.1. Business Overview
14.9.2. Company Snapshot
14.9.3. Company Market Share Analysis
14.9.4. Company Product Portfolio
14.9.5. Recent Developments
14.9.6. SWOT Analysis
14.10. Thermo Fisher Scientific
14.10.1. Business Overview
14.10.2. Company Snapshot
14.10.3. Company Market Share Analysis
14.10.4. Company Product Portfolio
14.10.5. Recent Developments
14.10.6. SWOT Analysis
14.11. QIAGEN
14.11.1. Business Overview
14.11.2. Company Snapshot
14.11.3. Company Market Share Analysis
14.11.4. Company Product Portfolio
14.11.5. Recent Developments
14.11.6. SWOT Analysis
14.12. Becton, Dickinson and Company
14.12.1. Business Overview
14.12.2. Company Snapshot
14.12.3. Company Market Share Analysis
14.12.4. Company Product Portfolio
14.12.5. Recent Developments
14.12.6. SWOT Analysis
14.13. Agilent Technologies
14.13.1. Business Overview
14.13.2. Company Snapshot
14.13.3. Company Market Share Analysis
14.13.4. Company Product Portfolio
14.13.5. Recent Developments
14.13.6. SWOT Analysis
14.14. PerkinElmer
14.14.1. Business Overview
14.14.2. Company Snapshot
14.14.3. Company Market Share Analysis
14.14.4. Company Product Portfolio
14.14.5. Recent Developments
14.14.6. SWOT Analysis
14.15. Bio-Techne Corporation
14.15.1. Business Overview
14.15.2. Company Snapshot
14.15.3. Company Market Share Analysis
14.15.4. Company Product Portfolio
14.15.5. Recent Developments
14.15.6. SWOT Analysis

List of Table
1. Global Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
2. Global Immunoassay Market, By Reagents & Kits, 2015–2025 (USD Billion
3. Global Reagents & Kits Immunoassay Market, By Region, 2015–2025 (USD Billion)
4. Global Analyzers Immunoassay Market, By Region, 2015–2025 (USD Billion)
5. Global Software & Services Immunoassay Market, By Region, 2015–2025 (USD Billion)
6. Global Immunoassay Market, By Platform, 2015–2025 (USD Billion)
7. Global Chemiluminescence Immunoassay Market, By Region, 2015–2025 (USD Billion)
8. Global Fluorescence Immunoassay Market, By Region, 2015–2025 (USD Billion)
9. Global Colorimetric Immunoassay Market, BY Region, 2015–2025 (USD Billion)
10. Global Radioimmunoassays Immunoassay Market, By Region, 2015–2025 (USD Billion)
11. Global Other Platforms Immunoassay Market, By Region, 2015–2025 (USD Billion)
12. Global Immunoassay Market, By Technology, 2015–2025 (USD Billion)
13. Global Enzyme-Linked Immunosorbent Immunoassay Market, By Region, 2015–2025 (USD Billion)
14. Global Rapid Tests Immunoassay Market, By Region, 2015–2025 (USD Billion)
15. Global Enzyme-Linked Immunospot Immunoassay Market, By Region, 2015–2025 (USD Billion)
16. Global Immuno-PCR Immunoassay Market, By Region, 2015–2025 (USD Billion)
17. Global Western Blotting Immunoassay Market, By Region, 2015–2025 (USD Billion)
18. Global Other Technologies Immunoassay Market, By Region, 2015–2025 (USD Billion)
19. Global Immunoassay Market, By Specimen, 2015–2025 (USD Billion)
20. Global Blood Immunoassay Market, By Region, 2015–2025 (USD Billion)
21. Global Saliva Immunoassay Market, By Region, 2015–2025 (USD Billion)
22. Global Urine Immunoassay Market, By Region, 2015–2025 (USD Billion)
23. Global Other Specimens Immunoassay Market, By Region, 2015–2025 (USD Billion)
24. Global Immunoassay Market, By Application, 2015–2025 (USD Billion)
25. Global Infectious Diseases Immunoassay Market, By Region, 2015–2025 (USD Billion)
26. Global Oncology Immunoassay Market, By Region, 2015–2025 (USD Billion)
27. Global Endocrinology Immunoassay Market, By Region, 2015–2025 (USD Billion)
28. Global Bone & Mineral Disorders Immunoassay Market, By Region, 2015–2025 (USD Billion)
29. Global Autoimmune Disorders Immunoassay Market, By Region, 2015–2025 (USD Billion)
30. Global Cardiology Immunoassay Market, By Region, 2015–2025 (USD Billion)
31. Global Neonatal Screening Immunoassay Market, By Region, 2015–2025 (USD Billion)
32. Global Hematology & Blood Screening Immunoassay Market, By Region, 2015–2025 (USD Billion)
33. Global Toxicology Immunoassay Market, By Region, 2015–2025 (USD Billion)
34. Global Immunoassay Market, By End User, 2015–2025 (USD Billion)
35. Global Hospitals Immunoassay Market, By Region, 2015–2025 (USD Billion)
36. Global Clinical Laboratories Immunoassay Market, By Region, 2015–2025 (USD Billion)
37. Global Pharmaceutical and Biotechnology Companies Immunoassay Market, By Region, 2015–2025 (USD Billion)
38. Global Blood Banks Immunoassay Market, By Region, 2015–2025 (USD Billion)
39. Global Research & Academic Laboratories Immunoassay Market, By Region, 2015–2025 (USD Billion)
40. Global Other End Users Immunoassay Market, By Region, 2015–2025 (USD Billion)
41. Global Immunoassay Market, By Region, 2015–2025 (USD Billion)
42. North America Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
43. North America Immunoassay Market, By Platform, 2015–2025 (USD Billion)
44. North America Immunoassay Market, By Technology 2015–2025 (USD Billion)
45. North America Immunoassay Market, By Specimen 2015–2025 (USD Billion)
46. North America Immunoassay Market, By Application, 2015–2025 (USD Billion)
47. North America Immunoassay Market, By End User, 2015–2025 (USD Billion)
48. U.S. Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
49. U.S. Immunoassay Market, By Platform, 2015–2025 (USD Billion)
50. U.S. Immunoassay Market, By Technology 2015–2025 (USD Billion)
51. U.S. Immunoassay Market, By Specimen 2015–2025 (USD Billion)
52. U.S. Immunoassay Market, By Cancer Product and service, 2015–2025 (USD Billion)
53. U.S. Immunoassay Market, By End User, 2015–2025 (USD Billion)
54. Canada Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
55. Canada Immunoassay Market, By Platform, 2015–2025 (USD Billion)
56. Canada Immunoassay Market, By Technology 2015–2025 (USD Billion)
57. Canada Immunoassay Market, By Specimen 2015–2025 (USD Billion)
58. Canada Immunoassay Market, By Application, 2015–2025 (USD Billion)
59. Canada Immunoassay Market, By End User, 2015–2025 (USD Billion)
60. Mexico Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
61. Mexico Immunoassay Market, By Platform, 2015–2025 (USD Billion)
62. Mexico Immunoassay Market, By Technology 2015–2025 (USD Billion)
63. Mexico Immunoassay Market, By Specimen 2015–2025 (USD Billion)
64. Mexico Immunoassay Market, By Application, 2015–2025 (USD Billion)
65. Mexico Immunoassay Market, By End User, 2015–2025 (USD Billion)
66. Europe Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
67. Europe Immunoassay Market, By Platform, 2015–2025 (USD Billion)
68. Europe Immunoassay Market, By Technology 2015–2025 (USD Billion)
69. Europe Immunoassay Market, By Specimen 2015–2025 (USD Billion)
70. Europe Immunoassay Market, By Application, 2015–2025 (USD Billion)
71. Europe Immunoassay Market, By End User, 2015–2025 (USD Billion)
72. Germany Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
73. Germany Immunoassay Market, By Platform, 2015–2025 (USD Billion)
74. Germany Immunoassay Market, By Technology 2015–2025 (USD Billion)
75. Germany Immunoassay Market, By Specimen 2015–2025 (USD Billion)
76. Germany Immunoassay Market, By Application, 2015–2025 (USD Billion)
77. Germany Immunoassay Market, By End User, 2015–2025 (USD Billion)
78. France Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
79. France Immunoassay Market, By Platform, 2015–2025 (USD Billion)
80. France Immunoassay Market, By Technology 2015–2025 (USD Billion)
81. France Immunoassay Market, By Specimen 2015–2025 (USD Billion)
82. France Immunoassay Market, By Application, 2015–2025 (USD Billion)
83. France Immunoassay Market, By End User, 2015–2025 (USD Billion)
84. Sweden Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
85. Sweden Immunoassay Market, By Platform, 2015–2025 (USD Billion)
86. Sweden Immunoassay Market, By Technology 2015–2025 (USD Billion)
87. Sweden Immunoassay Market, By Specimen 2015–2025 (USD Billion)
88. Sweden Immunoassay Market, By Application, 2015–2025 (USD Billion)
89. Sweden Immunoassay Market, By End User, 2015–2025 (USD Billion)
90. Netherlands Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
91. Netherlands Immunoassay Market, By Platform, 2015–2025 (USD Billion)
92. Netherlands Immunoassay Market, By Technology 2015–2025 (USD Billion)
93. Netherlands Immunoassay Market, By Specimen 2015–2025 (USD Billion)
94. Netherlands Immunoassay Market, By Application, 2015–2025 (USD Billion)
95. Netherlands Immunoassay Market, By End User, 2015–2025 (USD Billion)
96. U.K. Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
97. U.K. Immunoassay Market, By Platform, 2015–2025 (USD Billion)
98. U.K. Immunoassay Market, By Technology 2015–2025 (USD Billion)
99. U.K. Immunoassay Market, By Specimen 2015–2025 (USD Billion)
100. U.K. Immunoassay Market, By Application, 2015–2025 (USD Billion)
101. U.K. Immunoassay Market, By End User, 2015–2025 (USD Billion)
102. Italy Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
103. Italy Immunoassay Market, By Platform, 2015–2025 (USD Billion)
104. Italy Immunoassay Market, By Technology 2015–2025 (USD Billion)
105. Italy Immunoassay Market, By Specimen 2015–2025 (USD Billion)
106. Italy Immunoassay Market, By Application, 2015–2025 (USD Billion)
107. Italy Immunoassay Market, By End User, 2015–2025 (USD Billion)
108. Spain Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
109. Spain Immunoassay Market, By Platform, 2015–2025 (USD Billion)
110. Spain Immunoassay Market, By Technology 2015–2025 (USD Billion)
111. Spain Immunoassay Market, By Specimen 2015–2025 (USD Billion)
112. Spain Immunoassay Market, By Application, 2015–2025 (USD Billion)
113. Spain Immunoassay Market, By End User, 2015–2025 (USD Billion)
114. Turkey Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
115. Turkey Immunoassay Market, By Platform, 2015–2025 (USD Billion)
116. Turkey Immunoassay Market, By Technology 2015–2025 (USD Billion)
117. Turkey Immunoassay Market, By Specimen 2015–2025 (USD Billion)
118. Turkey Immunoassay Market, By Application, 2015–2025 (USD Billion)
119. Turkey Immunoassay Market, By End User, 2015–2025 (USD Billion)
120. Switzerland Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
121. Switzerland Immunoassay Market, By Platform, 2015–2025 (USD Billion)
122. Switzerland Immunoassay Market, By Technology 2015–2025 (USD Billion)
123. Switzerland Immunoassay Market, By Specimen 2015–2025 (USD Billion)
124. Switzerland Immunoassay Market, By Application, 2015–2025 (USD Billion)
125. Switzerland Immunoassay Market, By End User, 2015–2025 (USD Billion)
126. Belgium Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
127. Belgium Immunoassay Market, By Platform, 2015–2025 (USD Billion)
128. Belgium Immunoassay Market, By Application, 2015–2025 (USD Billion)
129. Belgium Immunoassay Market, By Technology 2015–2025 (USD Billion)
130. Belgium Immunoassay Market, By Specimen 2015–2025 (USD Billion)
131. Belgium Immunoassay Market, By End User, 2015–2025 (USD Billion)
132. Asia Pacific Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
133. Asia Pacific Immunoassay Market, By Platform, 2015–2025 (USD Billion)
134. Asia Pacific Immunoassay Market, By Technology 2015–2025 (USD Billion)
135. Asia Pacific Immunoassay Market, By Specimen 2015–2025 (USD Billion)
136. Asia Pacific Immunoassay Market, By Application, 2015–2025 (USD Billion)
137. Asia Pacific Immunoassay Market, By End User, 2015–2025 (USD Billion)
138. Japan Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
139. Japan Immunoassay Market, By Platform, 2015–2025 (USD Billion)
140. Japan Immunoassay Market, By Technology 2015–2025 (USD Billion)
141. Japan Immunoassay Market, By Specimen 2015–2025 (USD Billion)
142. Japan Immunoassay Market, By Application, 2015–2025 (USD Billion)
143. Japan Immunoassay Market, By End User, 2015–2025 (USD Billion)
144. China Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
145. China Immunoassay Market, By Platform, 2015–2025 (USD Billion)
146. China Immunoassay Market, By Technology 2015–2025 (USD Billion)
147. China Immunoassay Market, By Specimen 2015–2025 (USD Billion)
148. China Immunoassay Market, By Application, 2015–2025 (USD Billion)
149. China Immunoassay Market, By End User, 2015–2025 (USD Billion)
150. India Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
151. India Immunoassay Market, By Platform, 2015–2025 (USD Billion)
152. India Immunoassay Market, By Technology 2015–2025 (USD Billion)
153. India Immunoassay Market, By Specimen 2015–2025 (USD Billion)
154. India Immunoassay Market, By Application, 2015–2025 (USD Billion)
155. India Immunoassay Market, By End User, 2015–2025 (USD Billion)
156. South Korea Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
157. South Korea Immunoassay Market, By Platform, 2015–2025 (USD Billion)
158. South Korea Immunoassay Market, By Technology 2015–2025 (USD Billion)
159. South Korea Immunoassay Market, By Specimen 2015–2025 (USD Billion)
160. South Korea Immunoassay Market, By Application, 2015–2025 (USD Billion)
161. South Korea Immunoassay Market, By End User, 2015–2025 (USD Billion)
162. Australia Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
163. Australia Immunoassay Market, By Platform, 2015–2025 (USD Billion)
164. Australia Immunoassay Market, By Technology 2015–2025 (USD Billion)
165. Australia Immunoassay Market, By Specimen 2015–2025 (USD Billion)
166. Australia Immunoassay Market, By Application, 2015–2025 (USD Billion)
167. Australia Immunoassay Market, By End User, 2015–2025 (USD Billion)
168. Singapore Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
169. Singapore Immunoassay Market, By Platform, 2015–2025 (USD Billion)
170. Singapore Immunoassay Market, By Technology 2015–2025 (USD Billion)
171. Singapore Immunoassay Market, By Specimen 2015–2025 (USD Billion)
172. Singapore Immunoassay Market, By Application, 2015–2025 (USD Billion)
173. Singapore Immunoassay Market, By End User, 2015–2025 (USD Billion)
174. Malaysia Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
175. Malaysia Immunoassay Market, By Platform, 2015–2025 (USD Billion)
176. Malaysia Immunoassay Market, By Technology 2015–2025 (USD Billion)
177. Malaysia Immunoassay Market, By Specimen 2015–2025 (USD Billion)
178. Malaysia Immunoassay Market, By Application, 2015–2025 (USD Billion)
179. Malaysia Immunoassay Market, By End User, 2015–2025 (USD Billion)
180. Thailand Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
181. Thailand Immunoassay Market, By Platform, 2015–2025 (USD Billion)
182. Thailand Immunoassay Market, By Technology 2015–2025 (USD Billion)
183. Thailand Immunoassay Market, By Specimen 2015–2025 (USD Billion)
184. Thailand Immunoassay Market, By Application, 2015–2025 (USD Billion)
185. Thailand Immunoassay Market, By End User, 2015–2025 (USD Billion)
186. Indonesia Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
187. Indonesia Immunoassay Market, By Platform, 2015–2025 (USD Billion)
188. Indonesia Immunoassay Market, By Technology 2015–2025 (USD Billion)
189. Indonesia Immunoassay Market, By Specimen 2015–2025 (USD Billion)
190. Indonesia Immunoassay Market, By Application, 2015–2025 (USD Billion)
191. Indonesia Immunoassay Market, By End User, 2015–2025 (USD Billion)
192. Philippines Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
193. Philippines Immunoassay Market, By Platform, 2015–2025 (USD Billion)
194. Philippines Immunoassay Market, By Technology 2015–2025 (USD Billion)
195. Philippines Immunoassay Market, By Specimen 2015–2025 (USD Billion)
196. Philippines Immunoassay Market, By Application, 2015–2025 (USD Billion)
197. Philippines Immunoassay Market, By End User, 2015–2025 (USD Billion)
198. South America Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
199. South America Immunoassay Market, By Platform, 2015–2025 (USD Billion)
200. South America Immunoassay Market, By Technology 2015–2025 (USD Billion)
201. South America Immunoassay Market, By Specimen 2015–2025 (USD Billion)
202. South America Immunoassay Market, By Application, 2015–2025 (USD Billion)
203. South America Immunoassay Market, By End User, 2015–2025 (USD Billion)
204. Brazil Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
205. Brazil Immunoassay Market, By Platform, 2015–2025 (USD Billion)
206. Brazil Immunoassay Market, By Technology 2015–2025 (USD Billion)
207. Brazil Immunoassay Market, By Specimen 2015–2025 (USD Billion)
208. Brazil Immunoassay Market, By Application, 2015–2025 (USD Billion)
209. Brazil Immunoassay Market, By End User, 2015–2025 (USD Billion)
210. Argentina Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
211. Argentina Immunoassay Market, By Platform, 2015–2025 (USD Billion)
212. Argentina Immunoassay Market, By Technology 2015–2025 (USD Billion)
213. Argentina Immunoassay Market, By Specimen 2015–2025 (USD Billion)
214. Argentina Immunoassay Market, By Application, 2015–2025 (USD Billion)
215. Argentina Immunoassay Market, By End User, 2015–2025 (USD Billion)
216. Colombia Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
217. Colombia Immunoassay Market, By Platform, 2015–2025 (USD Billion)
218. Colombia Immunoassay Market, By Technology 2015–2025 (USD Billion)
219. Colombia Immunoassay Market, By Specimen 2015–2025 (USD Billion)
220. Colombia Immunoassay Market, By Application, 2015–2025 (USD Billion)
221. Colombia Immunoassay Market, By End User, 2015–2025 (USD Billion)
222. Middle East and Africa Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
223. Middle East and Africa Immunoassay Market, By Platform, 2015–2025 (USD Billion)
224. Middle East and Africa Immunoassay Market, By Technology 2015–2025 (USD Billion)
225. Middle East and Africa Immunoassay Market, By Specimen 2015–2025 (USD Billion)
226. Middle East and Africa Immunoassay Market, By Application, 2015–2025 (USD Billion)
227. Middle East and Africa Immunoassay Market, By End User, 2015–2025 (USD Billion)
228. Saudi Arabia Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
229. Saudi Arabia Immunoassay Market, By Platform, 2015–2025 (USD Billion)
230. Saudi Arabia Immunoassay Market, By Technology 2015–2025 (USD Billion)
231. Saudi Arabia Immunoassay Market, By Specimen 2015–2025 (USD Billion)
232. Saudi Arabia Immunoassay Market, By Application, 2015–2025 (USD Billion)
233. Saudi Arabia Immunoassay Market, By End User, 2015–2025 (USD Billion)
234. UAE Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
235. UAE Immunoassay Market, By Platform, 2015–2025 (USD Billion)
236. UAE Immunoassay Market, By Technology 2015–2025 (USD Billion)
237. UAE Immunoassay Market, By Specimen 2015–2025 (USD Billion)
238. UAE Immunoassay Market, By Application, 2015–2025 (USD Billion)
239. UAE Immunoassay Market, By End User, 2015–2025 (USD Billion)
240. Egypt Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
241. Egypt Immunoassay Market, By Platform, 2015–2025 (USD Billion)
242. Egypt Immunoassay Market, By Technology 2015–2025 (USD Billion)
243. Egypt Immunoassay Market, By Specimen 2015–2025 (USD Billion)
244. Egypt Immunoassay Market, By Application, 2015–2025 (USD Billion)
245. Egypt Immunoassay Market, By End User, 2015–2025 (USD Billion)
246. Nigeria Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
247. Nigeria Immunoassay Market, By Platform, 2015–2025 (USD Billion)
248. Nigeria Immunoassay Market, By Technology 2015–2025 (USD Billion)
249. Nigeria Immunoassay Market, By Specimen 2015–2025 (USD Billion)
250. Nigeria Immunoassay Market, By Application, 2015–2025 (USD Billion)
251. Nigeria Immunoassay Market, By End User, 2015–2025 (USD Billion)
252. South Africa Immunoassay Market, By Product and service, 2015–2025 (USD Billion)
253. South Africa Immunoassay Market, By Platform, 2015–2025 (USD Billion)
254. South Africa Immunoassay Market, By Technology 2015–2025 (USD Billion)
255. South Africa Immunoassay Market, By Specimen 2015–2025 (USD Billion)
256. South Africa Immunoassay Market, By Application, 2015–2025 (USD Billion)
257. South Africa Immunoassay Market, By End User, 2015–2025 (USD Billion)

List of Figures
1. Global Immunoassay Market Segmentation
2. Immunoassay Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Immunoassay Market attractiveness analysis by Product and service
9. Global Immunoassay Market attractiveness analysis by Platform
10. Global Immunoassay Market attractiveness analysis by Service
11. Global Immunoassay Market attractiveness analysis by Specimen
12. Global Immunoassay Market attractiveness analysis by Application
13. Global Immunoassay Market attractiveness analysis by Region
14. Global Immunoassay Market: Dynamics
15. Global Immunoassay Market Share by Product and Technology (2017 & 2025)
16. Global Immunoassay Market Share by Platform (2017 & 2025)
17. Global Immunoassay Market Share by Service (2017 & 2025)
18. Global Immunoassay Market Share by Specimen (2017 & 2025)
19. Global Immunoassay Market Share by Application (2017 & 2025)
20. Global Immunoassay Market Share by End User (2017 & 2025)
21. Global Immunoassay Market Share by Regions (2017 & 2025)
22. Global Immunoassay Market Share by Company (2018)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!